# Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009

> **NCT05134922** · — · AVAILABLE · sponsor: **Celcuity Inc**

## Conditions studied

- Breast Neoplasm Malignant Female

## Interventions

- **DRUG:** Gedatolisib

## Key facts

- **NCT ID:** NCT05134922
- **Lead sponsor:** Celcuity Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05134922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05134922, "Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05134922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*